Besides, a significant decrease was observed in the expression of RANKL in resting CD4+CD28− T cells from EA patients after 6 months of disease progression compared to baseline, whereas there is an increase in its expression in CD28+ cells. This evidence concerns the gene CD4 and Esophageal atresia.